TrialThe Journal of infectious diseases2013

Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.

Saran Vardhanabhuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.